Shanghai Baolijia Chemical Co., Ltd. (SHE:301037)
China · Delayed Price · Currency is CNY 15.90
+0.10 (0.63%)
At close: May 28, 2026
SHE:301037 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,602 | 1,673 | 2,136 | 2,252 | 2,988 | 2,965 |
Other Revenue | 16.88 | 16.88 | 14.75 | 17.37 | 175.12 | 9.79 |
| 1,619 | 1,690 | 2,151 | 2,269 | 3,163 | 2,975 | |
Revenue Growth (YoY) | -22.61% | -21.44% | -5.23% | -28.25% | 6.32% | 47.11% |
Cost of Revenue | 1,429 | 1,480 | 1,940 | 1,977 | 2,832 | 2,615 |
Gross Profit | 189.85 | 209.99 | 210.41 | 292.28 | 330.93 | 359.45 |
Selling, General & Admin | 182.31 | 187.3 | 222.2 | 232.17 | 223.44 | 199.63 |
Research & Development | 26.49 | 28.03 | 44.99 | 70.03 | 51.28 | 51.9 |
Other Operating Expenses | 8.66 | 8.38 | 4.4 | 6.17 | 10.29 | 7.44 |
Operating Expenses | 221.83 | 227.27 | 276.23 | 305.78 | 290.51 | 264.54 |
Operating Income | -31.98 | -17.27 | -65.82 | -13.5 | 40.42 | 94.91 |
Interest Expense | -37.24 | -39.37 | -38.6 | -34.6 | -41.74 | -37.84 |
Interest & Investment Income | 10.52 | 10.63 | 1.51 | 1.48 | 2.09 | 2.9 |
Other Non Operating Income (Expenses) | -3.89 | -2.5 | -10.72 | 0.19 | -0.98 | -2.47 |
EBT Excluding Unusual Items | -62.6 | -48.52 | -113.63 | -46.43 | -0.21 | 57.51 |
Gain (Loss) on Sale of Investments | 0.27 | - | -0.14 | -2.05 | -7.21 | - |
Gain (Loss) on Sale of Assets | 7.87 | 7.6 | 0.56 | 0.02 | 0.1 | 0.02 |
Asset Writedown | -14.66 | -12.29 | -17.46 | -0.55 | -0.53 | -0.03 |
Other Unusual Items | 5.11 | 5.11 | -3.95 | 7.04 | 10.59 | -0.57 |
Pretax Income | -64.01 | -48.11 | -134.63 | -41.98 | 2.75 | 56.93 |
Income Tax Expense | 7.09 | 7.4 | 15.32 | -10.48 | -2.99 | 6.48 |
Earnings From Continuing Operations | -71.1 | -55.51 | -149.96 | -31.5 | 5.74 | 50.45 |
Minority Interest in Earnings | 0.02 | 0.09 | 0.29 | 0.21 | - | - |
Net Income | -71.08 | -55.42 | -149.67 | -31.3 | 5.74 | 50.45 |
Net Income to Common | -71.08 | -55.42 | -149.67 | -31.3 | 5.74 | 50.45 |
Net Income Growth | - | - | - | - | -88.63% | -43.82% |
Shares Outstanding (Basic) | 139 | 139 | 139 | 141 | 140 | 119 |
Shares Outstanding (Diluted) | 139 | 139 | 139 | 141 | 140 | 119 |
Shares Change (YoY) | 0.09% | 0.01% | -1.08% | 0.32% | 18.33% | 14.00% |
EPS (Basic) | -0.51 | -0.40 | -1.08 | -0.22 | 0.04 | 0.43 |
EPS (Diluted) | -0.51 | -0.40 | -1.08 | -0.22 | 0.04 | 0.43 |
EPS Growth | - | - | - | - | -90.39% | -50.72% |
Free Cash Flow | -15.8 | 0.53 | -309.43 | 37.77 | -199.12 | -263.86 |
Free Cash Flow Per Share | -0.11 | 0.00 | -2.22 | 0.27 | -1.42 | -2.23 |
Dividend Per Share | - | - | - | - | - | 0.039 |
Gross Margin | 11.72% | 12.43% | 9.78% | 12.88% | 10.46% | 12.08% |
Operating Margin | -1.98% | -1.02% | -3.06% | -0.60% | 1.28% | 3.19% |
Profit Margin | -4.39% | -3.28% | -6.96% | -1.38% | 0.18% | 1.70% |
Free Cash Flow Margin | -0.98% | 0.03% | -14.39% | 1.66% | -6.30% | -8.87% |
EBITDA | 41.32 | 55.16 | 3.12 | 38.68 | 82.25 | 135.44 |
EBITDA Margin | 2.55% | 3.26% | 0.14% | 1.70% | 2.60% | 4.55% |
D&A For EBITDA | 73.31 | 72.43 | 68.94 | 52.17 | 41.83 | 40.53 |
EBIT | -31.98 | -17.27 | -65.82 | -13.5 | 40.42 | 94.91 |
EBIT Margin | -1.98% | -1.02% | -3.06% | -0.60% | 1.28% | 3.19% |
Effective Tax Rate | - | - | - | - | - | 11.38% |
Revenue as Reported | 1,619 | 1,690 | 2,151 | 2,269 | 3,163 | 2,975 |
Advertising Expenses | - | 2.22 | 4.27 | 1.6 | 0.86 | 0.31 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.